On the of Monoamine Oxidase, the Emotions, and Adaptation to Stress

References

• Anisman H., Remington G., Sklar L.S. Effect of inescapable shock on subsequent escape performance: Catecholaminergic and cholinergic mediation of response initiation and maintenance. Psychopharmacology 1979; 61: 107–124
   PubMed Web of Science ®Google Scholar
• Anisman H., Zalcman S., Shanks N., Zacharko R.M. Multisystem regulation of performance deficits induced by stressors: An animal model of depression. Neuromethods, Vol. 19: Animal Models in Psychiatry II, A. Boulton, G. Baker, M. Martin Inverson. Humana Press, Clifton, New Jersey 1991; 1–59
   Google Scholar
• Bebbington P.E., Brugha T., Mac Carthy B., Potter J., Sturt E., Wykes T., Katz R., McGuffin P. The Camberwell collaborative depression study: I. Depressed probands: Adversity and the form of depression. British Journal of Psychiatry 1988; 152: 754–765
   PubMed Web of Science ®Google Scholar
• Bland R.C., Newman S.C., Orn H. Period prevalence of psychiatric disorders in Edmonton. Acta Psychiatrica Scandinavica 1988; 77: 33–42, Suppl 338
   Web of Science ®Google Scholar
• Borsini F., Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity. Psychopharmacology 1988; 94: 147–160
   PubMed Web of Science ®Google Scholar
• Breslau N., Davis G.C. Chronic stress and major depression. Archives of General Psychiatry 1986; 43: 309–314
   PubMed Web of Science ®Google Scholar
• Brown G.W., Harris T. Stressor, vulnerability and depression: A question of replication. Psychological Medicine 1986; 16: 739–744
   PubMed Web of Science ®Google Scholar
• Commissaris R.L., Fontana D.J. Pharmacological evaluation of potential animal models for the study of antipanic and panicogenic treatment effects. Neuromethods, Vol. 19: Animal Models in Psychiatry II, A. Boulton, G. Baker, M. Martin Iverson. Humana Press, Clifton, New Jersey 1991; 199–232
   Google Scholar
• Crawley J.N. A monoamine oxidase inhibitor reverses the ‘separation syndrome’ in a new hamster separation model of depression. European Journal of Pharmacology 1985; 112: 129–133
   PubMed Web of Science ®Google Scholar
• Delay J., Laine B., Buisson J.F. Note concernant I'action de I'isonicotinylhydrazine dans le traitement des états depressifs. Annals of Medicine and Psychology 1952; 110: 689
   PubMedGoogle Scholar
• Fontana D.J., Carbary T.J., Commissaris R.L. Effects of acute and chronic anti-panic drug administration on conflict behavior in the rat. Psychopharmacology 1989; 98: 157–162
   PubMed Web of Science ®Google Scholar
• Garzon J., Fuentes J.A., Del Rio J. Antidepressants selectively antagonize the hyperactivity induced in rats by long-term isolation. European Journal of Pharmacology 1979; 59: 293–296
   PubMed Web of Science ®Google Scholar
• Glover V., Bhattacharya S.K., Sandler M. Isatin: A new biological factor. Indian Journal Experimental Biology 1991; 29: 1–5
   PubMed Web of Science ®Google Scholar
• Harmon D. Aging: A theory based on free radical and radiation chemistry. Journal of Gerontology 1956; 11: 298–300
   PubMedGoogle Scholar
• Jesberger J.A., Richardson J.S. Effects of antidepressant drugs on the behavior of olfactory bulbectomized and sham-operated rats. Behavioral Neuroscience 1986; 100: 256–274
   PubMed Web of Science ®Google Scholar
• Jesberger J.A., Richardson J.S. Brain output dysregulation induced by olfactory bulbectomy: An approximation in the rat of major depressive disorder in humans. International Journal of Neuroscience 1988; 38: 241–265
   PubMed Web of Science ®Google Scholar
• Jesberger J.A., Richardson J.S. Oxygen free radicals and brain dysfunction. International Journal of Neuroscience 1991; 49: 1–17
   Google Scholar
• Lehr E. Distress-call reactivation in isolated chicks: A behavioural indicator with high selectivity for antidepressants. Psychopharmacology 1989; 97: 145–146
   PubMed Web of Science ®Google Scholar
• Liebowitz M.R., Hollander E., Schneier F., Campeas R., Welkowitz L., Hatterer J., Fallon B. Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders. Acta Psychiatrica Scandinavica. Suppl 1990; 360: 29–34
   PubMedGoogle Scholar
• Lipsey J.R., Spencer W.C., Rabins P.V., Robinson R.G. Phenomenological comparison of post-stroke depression and functional depression. American Journal of Psychiatry 1986; 143: 527–529
   PubMed Web of Science ®Google Scholar
• Marek G.J., Seiden L.S. Selective inhibition of MAOA, not MAOB, results in antidepressant-like effects on DRL-72-s behavior. Psychopharmacology 1988; 96: 153–160
   PubMed Web of Science ®Google Scholar
• McGuffin P., Katz R., Aldrich J., Bebbington P. The Camberwell collaborative depression study: II: Investigation of family members. British Journal of Psychiatry 1988; 152: 766–774
   PubMed Web of Science ®Google Scholar
• McGuffin P., Katz R., Bebbington P. The Camberwell collaborative depression study: III: Depression and adversity in the relatives of depressed probands. British Journal of Psychiatry 1988; 152: 775–782
   PubMed Web of Science ®Google Scholar
• O'Donnell J.M., Seiden L.S. Effects of monoamine oxidase inhibitors on performance during differential reinforcement of low response rate. Psychopharmacology 1982; 78: 214–218
   PubMed Web of Science ®Google Scholar
• O'Donnell J.M., Seiden L.S. Differential-reinforcement-of-low-rate 72-second schedule: Selective effects of antidepressant drugs. Journal of Pharmacology and Experimental Therapeutics 1983; 224: 80–88
   PubMed Web of Science ®Google Scholar
• Otmakhova N.A., Gurevich E.V., Katkov Q.A., Nesterova I.V., Bobkova N.V. Dissociation of multiple behavioral effects of olfactory bulbectomy between C57B1/6j and DBA/2j mice. Physiology and Behavior 1992; 52, in press
   PubMed Web of Science ®Google Scholar
• Parkes C.M. Bereavement: Studies of Grief in Adult Life. Tavistock, London 1972
   Google Scholar
• Porsolt R.D., Bertin A., Blavet M., Deniel M., Jalfre M. Immobility induced by forced swimming in rats: Effects of agents which modify central catecholamine and serotonin activity. European Journal of Pharmacology 1979; 57: 201–210
   PubMed Web of Science ®Google Scholar
• Porsolt R.D., Chermat R., Simon P., Steru L. The tail suspension test: Computerized device for evaluating psychotropic activity profiles. Psychopharmacology 1986; 89: S28
   Web of Science ®Google Scholar
• Quitkin F.M., Rabkin J.G., Ross D., Stewart J.W. Defining the boundaries of atypical depression. Journal of Clinical Psychiatry 1984; 45: 19–21
   PubMed Web of Science ®Google Scholar
• Richardson J.S. On the analysis of catecholamines in animal models of depression. Progress in Catecholamine Research. Part C: Clinical Aspects, R. H. Belmaker, M. Sandler, A. Dahlstrom. Alan R. Liss., New York 1988a; 231–236
   Google Scholar
• Richardson J.S. On the neurobiology of depression: Research based on heterogenous diagnostic groups produces heterogenous biological data. Psychiatric Journal of the University: of Ottawa 1989a; 14: 433–434
   PubMedGoogle Scholar
• Richardson J.S. Study of olfactory bulbectomized rats: Revelations about major depressive disorder. New Directions in Affective Disorders, B. Lerer, S. Gershen. Springer-Verlag., New York 1989b; 9–12
   Google Scholar
• Richardson J.S. The olfactory bulbectomized rat as a model of major depressive disorder. Neuromethods, Vol. 19: Animal Models in Psychiatry II, A. Boulton, G. Baker, M. Martin Iverson. Humana Press., Clifton, New Jersey 1991a; 61–79
   Google Scholar
• Richardson J. S. Animal models of depression reflect changing views on the essence and etiology of depressive disorders in humans. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1991b; 15: 199–204
   PubMed Web of Science ®Google Scholar
• Richardson J.S., Musty R.E. Effects on the acquisition of DRL-20 performance of propranolol or isoproterenol injected into the basolateral amygdaia of rats. Canadian Journal of Physiology and Pharmacology 1974; 52: 1033–1035
   PubMed Web of Science ®Google Scholar
• Robins L.N., Helzer J.E., Weissman M., Orvaschel H., Gruenberg E., Burke J.D., Regier D.A. Lifetime prevalence of specific psychiatric disorders in three sites. Archives of General Psychiatry 1984; 41: 949–958
   PubMed Web of Science ®Google Scholar
• Schildkrant J.J., Kety S.S. Biogenic amines and emotions. Science 1967; 156: 21–30
   PubMed Web of Science ®Google Scholar
• Seligman M. E. P., Rossellini R.A., Kozak M. Learned helplessness in the rat: Reversibility, time course and immunization. Journal of Comparative and Phvsiological Psychology 1975; 88: 542–547
   PubMed Web of Science ®Google Scholar
• Sherman A.D., Sacquitne J.L., Petty F. Specificity of the learned helplessness model of depression. Pharmacology, Biochemistry and Behavior 1982; 16: 449–454
   PubMed Web of Science ®Google Scholar
• Shoulson I. Parkinson study group. Deprenyl and tocopherol antioxidant therapy of Parkinsonism (DATATOP). Acta Neurologica Scandinavica 1989; 80: 171–175, Suppl 126
   Google Scholar
• Steru L., Chermat R., Thieny B., Simon P. The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology 1985; 85: 367–370
   PubMed Web of Science ®Google Scholar
• Tatton W.E., Greenwood C.E. Rescue of dying neurons: A new action for deprenyl in MPTP parkinsonism. Journal of Neuroscience Research 1991; 30: 666–672
   PubMed Web of Science ®Google Scholar
• Tatton W.G., Salo P.T., Kwan M.M., Holland D.P., Graniou M., Greenwood C.E. Rescue of dying neurons by selegiline: Evidence for a trophic-like action. Canadian College of Neuropsychopharmacology, Abstracts 1992; 15: 11
   Google Scholar
• Van Riezen H., Leonard B.E. Effects of psychotropic drugs on the behaviour and neuro-chemistry of olfactory bulbectomized rats. Pharmacology and Therapeutics 1990; 47: 21–34
   PubMed Web of Science ®Google Scholar
• Watkins P., Clow A., Glover V., Halket J., Przyborowska A., Sandler M. Isatin, regional distribution in rat brain and tissues. Neurochemistry International 1990; 17: 321–323
   PubMed Web of Science ®Google Scholar
• Willner P. Animal models of depression. Behavioral Models in Psychopharmacology: Theoretical, Industrial and Clinical Perspectives, P. Willner. Cambridge University Press., Cambridge 1991; 91–125
   Google Scholar
• Zeller E.M., Barsky J. In vivo inhibition of liver and brain monoamine oxidase by 1-isonicotinyl-2-isopropyl hydrazine. Proceedings of the Society for Experimental Biology and Medicine 1952; 81: 459–461
   PubMed Web of Science ®Google Scholar